Ariadna T. Garcia

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Relative Mutant Allele Frequency Role in ctDNA-Guided Anti-Epidermal Growth Factor Receptor Rechallenge in Metastatic Colorectal Cancer.

Relative Mutant Allele Frequency Role in ctDNA-Guided Anti-Epidermal Growth Factor Receptor Rechallenge in Metastatic Colorectal Cancer.

Journal: JCO precision oncology

Published: September 01, 2026

Rechallenge With Anti-Human Epidermal Growth Factor Receptor 2 Therapy Guided by Liquid Biopsy in HER2-Amplified Metastatic Colorectal Cancer.

Rechallenge With Anti-Human Epidermal Growth Factor Receptor 2 Therapy Guided by Liquid Biopsy in HER2-Amplified Metastatic Colorectal Cancer.

Journal: JCO precision oncology

Published: July 29, 2026

Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients.

Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients.

Journal: Genes

Published: March 10, 2026

Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients.

Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Surrogate to predict overall survival in patients with BRAF V600E-mutant colorectal cancer treated with BRAF inhibitor combinations.

Surrogate to predict overall survival in patients with BRAF V600E-mutant colorectal cancer treated with BRAF inhibitor combinations.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Intratumoral Fusobacterium species and survival in resectable colorectal cancer: a multicenter cohort study.

Intratumoral Fusobacterium species and survival in resectable colorectal cancer: a multicenter cohort study.

Journal: ESMO open

Published: January 30, 2026

Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitors.

Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitors.

Journal: ESMO open

Published: December 23, 2025

Exploring resistance to immune checkpoints inhibitors in mismatch repair-deficient or microsatellite-instable colorectal cancer.

Exploring resistance to immune checkpoints inhibitors in mismatch repair-deficient or microsatellite-instable colorectal cancer.

Journal: Cancer treatment reviews

Published: October 05, 2025

Real-World Data of Patients with BRAF V600E-Mutated Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil.

Real-World Data of Patients with BRAF V600E-Mutated Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil.

Journal: Cancers

Published: November 12, 2024

Corrigendum to "Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments": [Annals of Oncology 34 (2023) 543-552].

Corrigendum to "Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments": [Annals of Oncology 34 (2023) 543-552].

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 13, 2024

Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer.

Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer.

Journal: International journal of molecular sciences

Published: May 31, 2024

Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapy.

Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapy.

Journal: Expert opinion on investigational drugs

Published: May 22, 2024

Showing 1-12 of 27

Last Updated: 09/26/2026